We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

EXPI:NASDAQeXp World Holdings, Inc. Analysis

Data as of 2026-06-11 - not real-time

$4.70

Latest Price

6/10Risk

Risk Level: Medium

Executive Summary

eXp World Holdings is trading at $4.70, well below its 20‑day SMA of $4.82 and the 50‑day SMA of $5.67, indicating a bearish price bias, yet the RSI of 37.6 suggests the stock is approaching oversold territory. Technical signals are mixed: the MACD histogram is positive and the MACD line sits just above the signal line, hinting at a potential short‑term bounce, while volume is on a decreasing trend and 30‑day volatility remains high at nearly 65%. Fundamentally, the company posted 8.5% revenue growth to $4.77 bn and reported an adjusted EBITDA of $4.1 m, up 88% YoY, with guidance pointing to $50‑$75 m of adjusted EBITDA for full‑year 2026. The balance sheet is strong—$124 m in cash, no debt, and free cash flow of $116 m—supporting a modest 3% dividend and a low payout ratio of 6%. A DCF‑derived fair value of $10.13 implies more than 100% upside, and the forward P/E of 19.8 is well below the industry average of 33, signaling potential undervaluation. However, operating margins remain negative and ROE is -10%, underscoring ongoing profitability challenges.
Given the high beta (~1.5‑2.2) and sector exposure to real‑estate cycles, price swings are likely, but the combination of improving EBITDA, strong cash generation, and a sizable valuation gap makes the stock a candidate for a tactical entry point, especially for investors comfortable with short‑term volatility.

Market Outlook

Short Term

< 1 year
Positive
Model confidence: 7/10

Key Factors

  • Price near support and oversold RSI
  • Positive MACD crossover
  • Strong cash flow and low debt

Medium Term

1–3 years
Positive
Model confidence: 8/10

Key Factors

  • Guidance for higher EBITDA and revenue
  • Undervalued relative to DCF and peers
  • Sustainable dividend with low payout

Long Term

> 3 years
Neutral
Model confidence: 7/10

Key Factors

  • Improving profitability trends but still negative margins
  • Exposure to real‑estate cycle risk
  • Continued dividend support and cash generation

Key Metrics & Analysis

Financial Health

Revenue Growth8.50%
Profit Margin-0.48%
P/E Ratio19.8
ROE-10.15%
ROA-3.22%
P/B Ratio4.5
Op. Cash Flow$118.6M
Free Cash Flow$116.5M
Industry P/E33.1

Technical Analysis

TrendBearish
RSI37.6
Support$4.50
Resistance$5.55
MA 20$4.82
MA 50$5.67
MA 200$8.56
MACDBullish
VolumeDecreasing
Fear & Greed Index84.39

Valuation

Fair Value$10.13
Target Price$9.50
Upside/Downside101.91%
GradeUndervalued
TypeBlend
Dividend Yield3.02%

Risk Assessment

Beta1.48
Volatility64.91%
Sector RiskMedium
Reg. RiskMedium
Geo RiskMedium
Currency RiskLow
Liquidity RiskMedium

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.